
Novo Nordisk A/S NVO
$ 44.87
1.07%
Annual report 2025
added 04-18-2026
Novo Nordisk A/S DIO Ratio 2011-2026 | NVO
Annual DIO Ratio Novo Nordisk A/S
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 338 | 318 | 305 | 288 | 285 | 247 | 259 | 273 |
All numbers in DKK currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 338 | 247 | 289 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
ACADIA Pharmaceuticals
ACAD
|
295 | $ 22.35 | 0.72 % | $ 3.7 B | ||
|
Galapagos NV
GLPG
|
0.915 | $ 28.39 | -0.13 % | $ 2.69 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.27 | 0.49 % | $ 6.83 B | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 23.42 | -0.3 % | $ 2.98 B | ||
|
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.64 | 4.46 % | $ 436 M | ||
|
Завод ДИОД
DIOD
|
768 | - | - | - | ||
|
Фармсинтез
LIFE
|
120 | - | - | - | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B |